nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications
|
Cho, Byoung Chul |
|
|
24 |
2 |
p. 89-97 |
artikel |
2 |
A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations
|
Heymach, John |
|
|
24 |
2 |
p. e65-e68 |
artikel |
3 |
Distinct Prognostic Impact of PET Findings Based on Radiological Appearance in Clinical Stage IA Lung Adenocarcinoma
|
Nakao, Masayuki |
|
|
24 |
2 |
p. 107-113 |
artikel |
4 |
Editorial Board
|
|
|
|
24 |
2 |
p. A1 |
artikel |
5 |
Epidemiological and Therapeutic Analyses in Lung Cancer Patients Over 80 Years Old in the Hokushin Region: A Retrospective Hospital Administrative Database Study
|
Koizumi, Tomonobu |
|
|
24 |
2 |
p. 145-152 |
artikel |
6 |
Frailty Index is Associated with Treatment Decisions for Stage I Non-Small Cell Lung Cancer at a High-Burden Safety-Net Hospital
|
Asokan, Sainath |
|
|
24 |
2 |
p. 153-164 |
artikel |
7 |
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study
|
Saltman, David L. |
|
|
24 |
2 |
p. 137-144 |
artikel |
8 |
Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report
|
Shantzer, Lindsey B. |
|
|
24 |
2 |
p. e60-e64 |
artikel |
9 |
Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net Hospital
|
Burns, Laura |
|
|
24 |
2 |
p. e69-e77 |
artikel |
10 |
Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)
|
Raez, Luis E. |
|
|
24 |
2 |
p. 120-129 |
artikel |
11 |
Pregnancy and Pathways to Motherhood in Oncogene-driven Lung Cancer: A Single Institution Experience
|
Simons, Emily A. |
|
|
24 |
2 |
p. e55-e59 |
artikel |
12 |
Pretreatment Platelet Count is a Prognostic Marker in Lung Cancer: A Danish Registry-based Cohort Study
|
Sandfeld-Paulsen, Birgitte |
|
|
24 |
2 |
p. 175-183 |
artikel |
13 |
Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy Planning
|
Beddok, Arnaud |
|
|
24 |
2 |
p. 98-106 |
artikel |
14 |
Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study
|
Li, Huiying |
|
|
24 |
2 |
p. e94-e104 |
artikel |
15 |
Table of Contents
|
|
|
|
24 |
2 |
p. A2-A4 |
artikel |
16 |
The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation
|
Dieleman, Edith |
|
|
24 |
2 |
p. 130-136 |
artikel |
17 |
The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer
|
Tani, Yoko |
|
|
24 |
2 |
p. 165-174 |
artikel |
18 |
The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study
|
Zhang, Chenchen |
|
|
24 |
2 |
p. e105-e112 |
artikel |
19 |
Timeliness of Lung Cancer Care From the Point of Suspicious Image at an Urban Safety Net Hospital
|
Siddiqi, Noreen |
|
|
24 |
2 |
p. e87-e93 |
artikel |
20 |
Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer
|
Kim, Kristine N. |
|
|
24 |
2 |
p. e78-e86 |
artikel |
21 |
Trends in Stage I Lung Cancer
|
Singareddy, Aashray |
|
|
24 |
2 |
p. 114-119 |
artikel |